Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

This article is part of the supplement: Beyond the Genome: The true gene count, human evolution and disease genomics

Invited speaker presentation

Translational medicine and the human microbiome

Rob Knight

  • Correspondence: Rob Knight

Author Affiliations

Dept of Chemistry and Biochemistry, University of Colarado at Boulder, Boulder, Colorado 80309, USA

Genome Biology 2010, 11(Suppl 1):I15  doi:10.1186/gb-2010-11-s1-i15


The electronic version of this article is the complete one and can be found online at: http://genomebiology.com/2010/11/S1/I15


Published:11 October 2010

© 2010 Knight; licensee BioMed Central Ltd.

Invited speaker presentation

We have learned much about the human microbiome, especially with advances in sequencing. However, as with the human genome, translating this knowledge into therapies remains challenging. One key advantage of focusing on the microbiome is that, outside of Star Trek, our genomes change little during our lifetime, yet each of our microbiomes has changed profoundly. Our microbiomes develop from an undifferentiated state that is dependent on delivery mode (i.e. vaginal delivery versus C-section) to the highly distinct communities that populate every crevice of our bodies.

Here I discuss the variation in the human microbiome within and between people, with a focus on the importance of spatially and temporally resolved studies, and the use of animal models, to gain insight into the role of microbes in obesity. Interestingly, many features of the microbiota of humans can be transferred into mice. The prospects for building a translational medicine pipeline, in which a single stool sample can be used to predict which interventions will work for which person, are compelling.